Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-28

FDA Approved: FINGOLIMOD — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for fingolimod submitted by Zydus Lifesciences Limited (ANDA 207994).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)